Background: Combination antiretroviral therapy (cART) reduces the risk of developing tuberculosis (TB) in persons with HIV both in low and high TB burden countries. Nonetheless, some studies suggest that this risk may remain above that of background HIV-uninfected populations. It is not clear whether in low TB burden countries the recommendation of guidelines to screen and treat for latent TB infection (LTBI) all persons with newly diagnosed HIV infection is presently justified.
Which is the current risk of tuberculosis in person diagnosed with in Italy?
G. Nunnari;G. F. Pellicanò.
2018-01-01
Abstract
Background: Combination antiretroviral therapy (cART) reduces the risk of developing tuberculosis (TB) in persons with HIV both in low and high TB burden countries. Nonetheless, some studies suggest that this risk may remain above that of background HIV-uninfected populations. It is not clear whether in low TB burden countries the recommendation of guidelines to screen and treat for latent TB infection (LTBI) all persons with newly diagnosed HIV infection is presently justified.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
